Browse 1,116 High Blood Pressure clinical trials enrolling across the United States and Canada. 94 people applied to High Blood Pressure studies last month. Search by city or state to find one near you.
High blood pressure, also called hypertension, is a common condition in which the force of blood against artery walls is consistently too high, increasing the risk of heart attack, stroke, and other complications.
Clinical trials for high blood pressure evaluate therapies to better control blood pressure and reduce cardiovascular risk, giving participants access to advanced treatments.
Reset Challenge: Reducing High-risk Drinking for Cancer Prevention
for
Alcohol Drinking, Heavy Drinking, Binge Drinking
Location: Tulsa OK
Sponsor: University of Oklahoma
Sex: All
Age: 18 - 70+
Code: NCT07591428
Recruiting
Active & Responsive
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
for
Coronavirus Disease (COVID-19)
Location: The Bronx NY, New York NY, Teaneck NJ, Newark NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06667700
Phase3, Recruiting
Active & ResponsiveNew
Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors
for
Periampullary Neoplasms, Pancreatic Cancer,
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 18+
Code: NCT07360119
Recruiting
Active & Responsive
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
for
Tachycardia, Ventricular
Location: Boston MA, Hartford CT, Philadelphia PA, Charleston SC,
Sponsor: Varian, a Siemens Healthineers Company
Sex: All
Age: 18+
Code: NCT05765175
Recruiting
Active & Responsive
Phase II Randomized, Placebo- Controlled Study of Intralesional Nivolumab for High-risk Oral Premalignant Lesions
for
Premalignant Lesion
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06561087
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
for
Neuroblastoma, Sarcoma
Location: The Bronx NY, Washington D.C. DC, Columbus OH,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 1 - 40
Code: NCT05135975
Phase2, Recruiting
Active & Responsive
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
for
Breast Neoplasms, Breast Cancer
Location: Norfolk VA, Nashville TN, Skokie IL, Houston TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06797635
Phase2, Recruiting
Active & Responsive
Preventing Suicidal Behavior With Diverse High-Risk Youth in Acute Care Settings
for
Suicide, Attempted, Suicide Ideation, Suicide,
Location: New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Johns Hopkins University
Sex: All
Age: 12 - 24
Code: NCT06151158
Recruiting
Active & Responsive
Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors
for
Solid Tumor
Location: Pittsburgh PA, Atlanta GA, St Louis MO, Houston TX
Sponsor: Emory University
Sex: All
Age: 1 - 30
Code: NCT04469530
Phase2, Recruiting
Active & Responsive
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
for
Breast Atypical Hyperplasia, Breast Carcinoma,
Location: Columbus OH, Chicago IL, Kansas City KS, Duarte CA
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 35+
Code: NCT05941520
Phase2, Recruiting
Active & Responsive
Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide Risk
for
Major Depressive Disorder (MDD), Suicidal Ideation
Location: Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 15 - 25
Code: NCT07025720
Recruiting
Active & Responsive
Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
for
Acute Leukemia, Myelodysplastic Syndrome
Location: Palo Alto CA
Sponsor: Laguna Biotherapeutics, Inc.
Sex: All
Age: 1 - 39
Code: NCT07573111
Phase1, Recruiting
Active & Responsive
Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis
for
JAK2 Mutation
Location: Boston MA
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 18+
Code: NCT07249840
Phase1, Recruiting
Active & Responsive
A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis
for
Secondary AML, Myelofibrosis
Location: San Diego CA, Duarte CA, Sacramento CA
Sponsor: Aspera Biomedicines, Inc.
Sex: All
Age: 18+
Code: NCT07250646
Phase1, Recruiting
Active & Responsive
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
for
Non-small Cell Lung Cancer
Location: New Haven CT, White Plains NY, Albany NY, Montreal,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07513376
Phase3, Recruiting
Active & Responsive
A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer
for
Pancreatic Ductal Adenocarcinoma
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 50 - 70+
Code: NCT07324096
Recruiting
Active & Responsive
Personalized Neoantigen Vaccine Plus IL-12 (INO-9012) Versus Active Surveillance in Subjects With High-Risk HCC
for
HCC
Location: New York NY, Baltimore MD, New Orleans LA
Sponsor: Geneos Therapeutics
Sex: All
Age: 18+
Code: NCT07722741
Phase2, Recruiting
Active & Responsive
Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia